Publication Cover
Xenobiotica
the fate of foreign compounds in biological systems
Volume 25, 1995 - Issue 9
59
Views
21
CrossRef citations to date
0
Altmetric
Research Article

Determination of P4501A2 activity in human liver microsomes using [3-14C-methyl]caffeine

, &
Pages 917-927 | Received 18 Feb 1995, Published online: 22 Sep 2008

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (5)

Dennis Rokitta, Kay Pfeiffer, Christina Streich, Henrik Gerwin & Uwe Fuhr. (2013) The effect of organic solvents on enzyme kinetic parameters of human CYP3A4 and CYP1A2 in vitro. Toxicology Mechanisms and Methods 23:8, pages 576-583.
Read now
Slobodan Rendic. (2002) Summary of information on human CYP enzymes: human P450 metabolism data. Drug Metabolism Reviews 34:1-2, pages 83-448.
Read now
H. Yin, J. Racha, S.-Y. Li, N. Olejnik, H. Satoh & D. Moore. (2000) Automated high throughput human CYP isoform activity assay using SPE-LC/MS method: application in CYP inhibition evaluation. Xenobiotica 30:2, pages 141-154.
Read now
S. E. CLARKE. (1998) In vitro assessment of human cytochrome P450. Xenobiotica 28:12, pages 1167-1202.
Read now

Articles from other publishers (16)

Zeyad Alehaideb, Mohamed Sheriffdeen & Francis C. P. Law. (2021) Inhibition of Caffeine Metabolism by Apiaceous and Rutaceae Families of Plant Products in Humans: In Vivo and In Vitro Studies. Frontiers in Pharmacology 12.
Crossref
Javor Mitkov, Magdalena Kondeva-Burdina & Alexander Zlatkov. (2019) Synthesis and preliminary hepatotoxicity evaluation of new caffeine-8-(2-thio)-propanoic hydrazid-hydrazone derivatives. Pharmacia 66:3, pages 99-106.
Crossref
Mohamed M. Sheriffdeen, Zeyad I. Alehaideb & Francis C.P. Law. (2019) Caffeine/Angelica dahurica and caffeine/Salvia miltiorrhiza metabolic inhibition in humans: In vitro and in vivo studies. Complementary Therapies in Medicine 46, pages 87-94.
Crossref
Zeyad Alehaideb, Kimberly C. Chin, Mei Cun Yao & Francis C.P. Law. (2019) Predicting the content of anthraquinone bioactive in Rhei rhizome (Rheum officinale Baill.) with the concentration addition model. Saudi Pharmaceutical Journal 27:1, pages 25-32.
Crossref
Mohamed B. Abou-Donia. 2015. Mammalian Toxicology. Mammalian Toxicology 101 129 .
Angela Dudda & Gert Ulrich Kuerzel. 2013. Drug Discovery and Evaluation: Safety and Pharmacokinetic Assays. Drug Discovery and Evaluation: Safety and Pharmacokinetic Assays 989 1004 .
Dan Rock, Jan Wahlstrom & Larry Wienkers. 2008. Antitargets. Antitargets 195 246 .
Angela Dudda & Gert Ulrich Kürzel. 2006. Drug Discovery and Evaluation. Drug Discovery and Evaluation 551 557 .
Kiyomi Ito & J. Brian Houston. (2005) Prediction of Human Drug Clearance from in Vitro and Preclinical Data Using Physiologically Based and Empirical Approaches. Pharmaceutical Research 22:1, pages 103-112.
Crossref
Jagdish K. Racha, Z. Sylvia Zhao, Nicholas Olejnik, Nadine Warner, Rebecca Chan, David Moore & Hiroko Satoh. (2003) Substrate Dependent Inhibition Profiles of Fourteen Drugs on CYP3A4 Activity Measured by A High Throughput LCMS/MS Method with Four Probe Drugs, Midazolam, Testosterone, Nifedipine and Terfenadine. Drug Metabolism and Pharmacokinetics 18:2, pages 128-138.
Crossref
Florence Grand, Izzet Kilinc, Albert Sarkis & Jérôme Guitton. (2002) Application of Isotopic Ratio Mass Spectrometry for the in Vitro Determination of Demethylation Activity in Human Liver Microsomes Using N-methyl-13C-Labeled Substrates. Analytical Biochemistry 306:2, pages 181-187.
Crossref
Enock Delaporte & A. David Rodrigues. (2002) Cytochrome P450 Assays. Current Protocols in Pharmacology 15:1.
Crossref
Mohamed Abou-Donia, Eman Elmasry & Aqel Abu-Qare. 2001. Handbook of Toxicology, Second Edition. Handbook of Toxicology, Second Edition.
Baldwin, Clarke & Chenery. (1999) Characterization of the cytochrome P450 enzymes involved in the in vitro metabolism of rosiglitazone . British Journal of Clinical Pharmacology 48:3, pages 424-432.
Crossref
Robert J. Riley & D. Howbrook. (1997) In vitro analysis of the activity of the major human hepatic CYP enzyme (CYP3A4) using [N-methyl-14C]-erythromycin. Journal of Pharmacological and Toxicological Methods 38:4, pages 189-193.
Crossref
A. David Rodrigues & Shekman L. Wong. 1997. 65 101 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.